2.490USD-1.58%Mkt Cap: 226.33M USDP/E: —Last update: 2026-05-22
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, …
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap226.33M USD
Enterprise Value237.73M USD
Revenue (TTM)78.09M USD
Gross Profit61.05M USD
Net Income (TTM)-43.97M USD
Revenue/Share0.8750 USD
Last Price2.490 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees146
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS1920051067
Valuation
P/E (Trailing)—
P/E (Forward)-6.84
PEG13.53
EV/EBITDA-11.57
EV/Revenue3.04
P/S2.94
P/B5.32
EPS (TTM)-0.35
EPS (Forward)-0.37
52W Range
0.960053% of range3.870
52W High3.870 USD
52W Low0.9600 USD
Profitability
Gross Margin86.73%
Oper. Margin-52.75%
EBITDA Margin-26.31%
Profit Margin-62.47%
ROE-87.03%
ROA-29.75%
Growth
Revenue Growth102.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.38M USD
CapEx (TTM)4.47M USD
FCF Margin-10.85%
FCF Yield-3.75%
Net Debt7.76M USD
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity1.45
Current Ratio5.36
Quick Ratio4.93
Book Value/Sh0.4760 USD
Cash/Share0.7170 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)6.583 USD
Target Range2.000 USD – 11.00 USD
# Analysts6
Ownership
Shares Out.90.90M
Float72.98M
Insiders7.41%
Institutions74.35%
Short Interest
Short Ratio3.3d
Short % Float5.22%
Short % Out.5.14%
Shares Short4.68M
Short (prev mo.)6.94M
Technical
SMA 502.232 (+11.6%)
SMA 2002.046 (+21.7%)
Beta2.53
S&P 52W Chg28.31%
Avg Vol (30d)1.18M
Avg Vol (10d)965.71K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—